The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
According to Fortune Business Insights, the recombinant vaccines market share was valued at USD 39.25 billion in 2024 and is projected to grow from USD 41.59 billion in 2025 to USD 84.30 billion by 2032, exhibiting a CAGR of 10.62% during the forecast period. North America dominated the recombinant vaccines market, accounting for a 49.14% share in 2024.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search